How Long Does Semaglutide Take to Work?
Medically reviewed by
Dr. Bhavesh Patel, D.O., Founder, Internal Medicine Physician
Published · Medically reviewed
Semaglutide works over months, not days. In the 68-week STEP 1 trial, weight loss was already measurable at the first check, at week 4, and kept building until about week 60. The average loss at week 68 was 14.9 percent of body weight, against 2.4 percent on placebo. The first 16 weeks run below the full dose, which is stepped up gradually.
Key takeaways
- Weeks to start, months to finish. In the STEP 1 trial, average weight was already down at the first check at week 4 and did not reach its lowest point until week 60.
- The early weeks run below the full dose. The label steps the dose up over 16 weeks to limit stomach side effects, and the drug's half-life of about 1 week means levels build gradually.
- Averages hide a wide spread. At week 68 the average loss was 14.9 percent, yet 13.6 percent of people on semaglutide had lost less than 5 percent.
Why does semaglutide take weeks to show its full effect?
Two things slow the start, and both are deliberate. The first is the drug itself. The prescribing information gives semaglutide an elimination half-life of about 1 week, which is why it is injected once weekly and why it stays in the circulation for about 5 to 7 weeks after the last dose. A drug that clears that slowly also builds up slowly.
The second is the dosing. The label starts low and raises the dose in four steps, each lasting 4 weeks, to reduce the risk of stomach side effects, so the maintenance dose arrives at week 17. For those first 16 weeks you are taking less than the dose the trial results are based on. The label says semaglutide decreases calorie intake, most likely by acting on appetite.
What did the weight loss curve look like in the trials?
STEP 1 is the clearest picture. It enrolled 1,961 adults without diabetes who had a body mass index of 30 or more, or 27 or more with a weight-related condition, and ran for 68 weeks. Everyone, including the placebo group, was asked to cut 500 calories a day and do 150 minutes of physical activity a week.
| Time point | What STEP 1 reported for semaglutide |
|---|---|
| Week 4 | The first check after starting. Weight loss was already observed, and it continued from here onward. |
| Week 16 | The maintenance dose was reached, after a dose increase every 4 weeks. |
| Week 60 | Average weight reached its lowest point. |
| Week 68 | Average change of 14.9 percent of body weight lost, against 2.4 percent on placebo, a difference of 12.4 percentage points. |
These are trial averages, not a forecast for one person. At week 68, 86.4 percent of people on semaglutide had lost at least 5 percent of their weight and 50.5 percent had lost at least 15 percent. On placebo the figures were 31.5 and 4.9 percent. The published report gives exact averages only for week 68.
What makes your timeline faster or slower?
Type 2 diabetes. In STEP 2, which enrolled 1,210 adults with type 2 diabetes for the same 68 weeks, the average loss on the same dose was 9.6 percent, against 3.4 percent on placebo. The tirzepatide vs. semaglutide comparison sets those trials side by side.
How the dose steps go. If a dose is not tolerated, the label says to consider delaying the next increase by 4 weeks. Each delay pushes the maintenance dose back by a month. Stomach side effects are the usual reason, and the semaglutide side effects timeline covers when they tend to ease.
What you do alongside it. The drug is labelled for use in combination with a reduced calorie diet and increased physical activity, to reduce excess body weight and maintain the reduction long term in adults with obesity, or with overweight and at least one weight-related condition. The STEP 1 results came with a 500 calorie daily deficit and 150 minutes of weekly activity built in.
What should you do if progress stalls?
Expect it at some point. In STEP 1 the average weight stopped falling at week 60 even though treatment continued, so a stall late in the first year is the normal shape of the curve. Our page on a weight loss plateau explains why the body pushes back.
The label sets no fixed checkpoint for stopping. It says to consider treatment response and tolerability when selecting the maintenance dosage, which makes dose changes, switching and whether to continue decisions for a visit. Here, follow-up is with Dr. Bhavesh Patel himself, in person or by telehealth.
While the scale is moving, protect muscle. A 2025 joint advisory from four nutrition and obesity societies reports that 5.3 kg of the average 13.6 kg lost in STEP 1 was lean mass. It advises strength training at least 3 times a week, and it warns that extra protein alone is unlikely to preserve muscle without it. More on muscle preservation during weight loss.
When should you call your provider?
Slow progress can wait for your next visit. These cannot. The medication guide says to stop the drug and call right away for severe stomach pain that will not go away, with or without nausea or vomiting, which can be a sign of pancreatitis. Call for pain in the upper stomach, fever, yellowing of the skin or eyes, or clay-colored stools, which can point to gallbladder problems.
Tell your provider right away about nausea, vomiting or diarrhea that does not go away. The label reports kidney injury in people taking semaglutide, and the majority of those cases followed dehydration from exactly those symptoms, so keep drinking fluids.
To find out what a realistic timeline looks like for you, contact the Artesia office for a free assessment. More GLP-1 guides are on the blog.
Frequently asked questions
How fast does semaglutide work for appetite?
The label says semaglutide decreases calorie intake, most likely by acting on appetite, but it gives no onset time. The studies that measured eating did so weeks in: one found calorie intake at a test meal 35 percent lower than placebo at week 20, and an earlier study at a lower dose found a 24 percent reduction after 12 weeks.
What is a normal semaglutide weight loss timeline over the first year?
In STEP 1, average weight was already down at week 4, the maintenance dose was reached by week 16, and the lowest average weight came at week 60. The average loss at week 68 was 14.9 percent, against 2.4 percent on placebo. Those are averages from one trial, and individual results spread widely around them.
Why am I not losing weight in my first month on semaglutide?
The first month is spent on the starting dose. The label raises the dose in 4-week steps and the maintenance dose does not arrive until week 17, while a half-life of about 1 week means drug levels build gradually. A slow first month is not a verdict: even at week 68, 13.6 percent of people on semaglutide in STEP 1 had lost less than 5 percent.
Does semaglutide work more slowly if you have type 2 diabetes?
It produced less weight loss in the trial that tested it. Adults with type 2 diabetes in STEP 2 lost an average of 9.6 percent over 68 weeks, compared with 14.9 percent in STEP 1, which enrolled adults without diabetes. The two were separate trials, so the comparison is indirect.
How long does semaglutide stay in your body after a dose?
The prescribing information gives an elimination half-life of about 1 week, meaning blood levels fall by half roughly every week. It states that semaglutide will be present in the circulation for about 5 to 7 weeks after the last dose. That long tail is why effects and side effects fade gradually.
Sources
- Novo Nordisk. FDA prescribing information, semaglutide injection and tablets (weight management), with Medication Guide, revised June 2026. DailyMed, US National Library of Medicine, 2026.
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine, 2021.
- Davies M, Faerch L, Jeppesen OK, et al. Semaglutide once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). The Lancet, 2021.
- Mozaffarian D, Agarwal M, Aggarwal M, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. American Journal of Clinical Nutrition, 2025.
- Friedrichsen M, Breitschaft A, Tadayon S, Wizert A, Skovgaard D. The effect of semaglutide once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity. Diabetes, Obesity and Metabolism, 2021.
- Blundell J, Finlayson G, Axelsen M, et al. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes, Obesity and Metabolism, 2017.
At Rx2BFIT, Semaglutide treatment is physician-guided by Dr. Bhavesh Patel, D.O. at 17828 Pioneer Blvd, Suite 102, Artesia, CA 90701. Every plan starts with a free assessment, and the best way to find out what fits your body and goals is to call (562) 650-0069.
This is general information, not medical advice. Whether a treatment is right for you is determined by a licensed provider after an evaluation.